GlassScriptPhysician profile
George Williams
NPI 1477318848
$2,150.61
in general payments reported to CMS, 2019-2025
11 companies · $1,944 in 2025
The $1,944 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $207 · 2025: $1,944.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,534 · Travel and Lodging: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,533.83 |
| Travel and Lodging | $616.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,095.44 | 2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Abbvie INC. | $340.08 | 2025 | |
| Curonix LLC | $293.82 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nalu Medical, INC. | $107.10 | 2024 | Nalu Neurostimulation System |
| Medtronic, INC. | $100.24 | 2025 | Inceptiv, Synchromedii, Vanta Adaptivestim |
| Averitas Pharma INC. | $48.88 | 2025 | Qutenza |
| Collegium Pharmaceutical, INC. | $42.84 | 2024 | Belbuca |
| Spinal Simplicity, LLC | $35.88 | 2025 | Ha Minuteman G3-R |
| Xeris Pharmaceuticals, INC. | $30.78 | 2025 | Keveyis |
| Mml US, INC. | $30.34 | 2025 | Reactiv8 |
| Avanos Medical | $25.21 | 2024 | Standard Rf Disposables |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.